reSurge

Randomized Trial on Surgery for Glioblastoma Recurrence

Information

Here you find details about the ReSurge trial and its purpose.

Learn more

Community

24 centers from all over the world are part of the ReSurge trial.

Learn more

Patients

Here we provide the progress of the ReSurge trial recruitment

Learn more

Documents

Participating centers can find all study related documents here.

Learn more

Background

Patients with glioblastoma face a grim prognosis. Despite recent advancement in neurosurgical technology and neuro-oncology glioblastomas almost invariably progress or recur.

Learn more about the trial

Objectives

The primary objective of this trial is to compare survival outcome after surgery followed by adjuvant second-line therapy to no surgery followed by second-line therapy in recurrent glioblastoma.

Learn more about the trial

Latest News

Keep track on the Trial process

Expanding across Europe!

Since early 2025, the Resurge Trial has significantly expanded its European presence. We’re thrilled to announce NEW additions complementing our already active sites: This growth strengthens our ability to engage[…]

Read more
July 9, 2025 0

Thank you!

The ReSurge trial could achieve an increasing recruitment rate during the last year. This is great, especially in view of the pandemia which accompanies us for over a year now.[…]

Read more
February 1, 2021 0

New patients in

Also the newly opened sites in Larisa, Erfurt and Mainz could recuit their first patient. Moreover, one more patient was recruited in Lausanne and six in Bern.In total 36 patients[…]

Read more
December 10, 2019 0